Sensitization to the dopamine agonist quinpirole as an animal model of OCD
Szechtman, H.; Culver, K.; Eilam, D.
Society for Neuroscience Abstracts 25(1-2): 1800
1999
ISSN/ISBN: 0190-5295 Accession: 035711953
PDF emailed within 1 workday: $29.90
Related References
Eilam, D.; Szechtman, H. 1995: Towards an animal model of obsessive-compulsive disorder Sensitization to dopamine agonist quinpirole Society for Neuroscience Abstracts 21(1-3): 192Johnson, E.F.; Szechtman, H. 2016: A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity Behavioural Pharmacology 27(5): 439-450
Perreault, M.L.; Graham, D.; Scattolon, S.; Wang, Y.; Szechtman, H.; Foster, J.A. 2007: Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats Psychopharmacology 194(4): 485-496
Hatalova, H.; Radostova, D.; Pistikova, A.; Vales, K.; Stuchlik, A. 2017: Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole Behavioural Brain Research 317: 210-217
Beerepoot, P.; Lam, V.; Luu, A.; Tsoi, B.; Siebert, D.; Szechtman, H. 2008: Effects of Salvinorin A on Locomotor Sensitization to D2/D3 Dopamine Agonist Quinpirole Neuroscience Letters 446(2-3): 101-104
Willner, P..; Papp, M..; Cheeta, S..; Muscat, R.. 1992: Environmental influences on behavioural sensitization to the dopamine agonist quinpirole Behavioural Pharmacology 3(1): 43-50
Szechtman, H..; Talangbayan, H..; Eilam, D.. 1993: Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole Behavioural Pharmacology 4(4): 405-410
Einat, H.; Einat, D.; Allan, M.; Talangbayan, H.; Tsafnat, T.; Szechtman, H. 1996: Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole Psychopharmacology 127(2): 95-101
Lomanowska, A.; Gormley, S.; Szechtman, H. 2004: Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 77(3): 617-622
Culver, K.E.; Szechtman, H. 2004: Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOi clorgyline Hormones and Behavior 45(1): 23-30
Szechtman, H.; Dai, H.; Mustafa, S.; Einat, H.; Sullivan, R.M. 1994: Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 48(4): 921-928
D'Aquila, P.S.; Peana, A.T.; Tanda, O.; Serra, G. 2001: Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole European Journal of Pharmacology 416(1-2): 107-111
Einat, H.; Szechtman, H. 1996: Influence of practice and environment-drug pairing on the expression of sensitization induced by the dopamine agonist quinpirole Society for Neuroscience Abstracts 22(1-3): 475
Culver, K.E.; Szechtman, H. 1999: The effect of intermittent and continuous clorgyline administration on locomotor sensitization induced by the dopamine agonist quinpirole Society for Neuroscience Abstracts 25(1-2): 1214
Szechtman, H.; Talangbayan, H.; Canaran, G.; Dai, H.; Eilam, D. 1994: Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism Psychopharmacology 115(1-2): 95-104
D'aquila, P.S.; Collu, M.; Devoto, P.; Serra, G. 2000: Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D(2)-like receptor agonist quinpirole European Journal of Pharmacology 395(2): 157-160
D'Aquila, P.S.; Panin, F.; Serra, G. 2006: Chronic valproate fails to prevent imipramine-induced behavioural sensitization to the dopamine D2-like receptor agonist quinpirole European Journal of Pharmacology 535(1-3): 208-211
Jung, T.D.; Jung, P.S.; Raveendran, L.; Farbod, Y.; Dvorkin-Gheva, A.; Sakic, B.; Surette, M.G.; Szechtman, H. 2018: Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole Behavioural Pharmacology 29(2 and 3-Spec Issue): 211-224
Jake Matthews, C.; Vezina, P. 1995: Cues specifically unpaired with amphetamine attenuate the development of locomotor sensitization to the D-2 dopamine receptor agonist quinpirole Society for Neuroscience Abstracts 21(1-3): 2089
Dvorkin, A.; Perreault, M.L.; Szechtman, H. 2006: Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder Behavioural Brain Research 169(2): 303-311